Advertisement
Canada markets close in 2 hours 36 minutes
  • S&P/TSX

    21,996.10
    +110.72 (+0.51%)
     
  • S&P 500

    5,111.77
    +63.35 (+1.25%)
     
  • DOW

    38,310.37
    +224.57 (+0.59%)
     
  • CAD/USD

    0.7315
    -0.0008 (-0.11%)
     
  • CRUDE OIL

    83.94
    +0.37 (+0.44%)
     
  • Bitcoin CAD

    87,180.70
    -975.16 (-1.11%)
     
  • CMC Crypto 200

    1,324.11
    -72.43 (-5.19%)
     
  • GOLD FUTURES

    2,349.30
    +6.80 (+0.29%)
     
  • RUSSELL 2000

    2,003.39
    +22.27 (+1.12%)
     
  • 10-Yr Bond

    4.6710
    -0.0350 (-0.74%)
     
  • NASDAQ

    15,966.04
    +354.28 (+2.27%)
     
  • VOLATILITY

    15.06
    -0.31 (-2.02%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6837
    +0.0016 (+0.23%)
     

Cabot: Fiscal 4Q Earnings Snapshot

BOSTON (AP) _ Cabot Corp. (CBT) on Monday reported a fiscal fourth-quarter loss of $272 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Boston-based company said it had a loss of $4.81. Earnings, adjusted for pretax expenses and asset impairment costs, were 68 cents per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 58 cents per share.

The chemical company posted revenue of $659 million in the period.

For the year, the company reported a loss of $238 million, or $4.21 per share, swinging to a loss in the period. Revenue was reported as $2.61 billion.

ADVERTISEMENT

Cabot shares have dropped 7% since the beginning of the year. In the final minutes of trading on Monday, shares hit $44.11, a decline of slightly more than 6% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CBT at https://www.zacks.com/ap/CBT